Nano device seeks to detect disease outbreaks
May 22, 2018
A medical electronic device from Texas-based Nano Global seeks to enable earlier alerts of disease outbreaks in hospitals and high-risk areas. It combines an array of sensors with an Arm processor to understand and create a database of environmental conditions in the early phases of an infectious outbreak.
The company is working with research and clinical partners in the USA to monitor and record conditions and, in the event of an outbreak, understand what changed.
The limited release of the first generation Nano Bot device is to monitor and convey environmental data critical to human health and disease control. It will be deployed initially at healthcare and research facilities operated by some of Nano’s close strategic partners.
This marks an important milestone in Nano’s ability to monitor sensitive environments for health threats by collecting ambient environmental information to understand, predict and rectify threats such as antimicrobial resistance (AMR) and superbugs. Data acquired through Nano Bots provide an important data stream to the company’s broader data-driven Nano Sense artificial intelligence platform.
“Implementing this technology in healthcare facilities aligns perfectly with our mission to provide the best care for patients while furthering important research to better understand how our environment creates and contributes to health threats,” said Peter Hotez, professor of paediatrics and molecular virology and microbiology at Baylor College of Medicine.
The Nano Sense system-on-chip (SoC), under development in partnership with Arm, will power future Nano Bot and partner devices to enable data acquisition and AI at the edge, accelerating detection, prevention and treatment of health threats.
“For Nano and its affiliates, the release of our first-generation Nano Bot device signals an important step in our mission to help fight global health threats,” said Steve Papermaster, chairman and CEO of Nano. “We believe our technology platform is a game-changer for detecting and understanding critical elements of health and look forward to building on this exciting momentum.”